scholarly article | Q13442814 |
P50 | author | John G Hay | Q55267033 |
Harald Sauthoff | Q55267036 | ||
P2093 | author name string | David I Kutler | |
William N Rom | |||
Sofia Bajwa | |||
Jin Cheng | |||
YaoQi Huang | |||
P2860 | cites work | Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity | Q28570872 |
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein | Q33807026 | ||
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? | Q34225918 | ||
New insights into the role of extracellular matrix during tumor onset and progression. | Q34747421 | ||
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider | Q35043121 | ||
Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers | Q36252226 | ||
Recent progress in the battle between oncolytic viruses and tumours | Q36315580 | ||
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects | Q36336364 | ||
Selective intratumoral amplification of an antiangiogenic vector by an oncolytic virus produces enhanced antivascular and anti-tumor efficacy | Q40318387 | ||
Effect of hypoxia on Ad5 infection, transgene expression and replication. | Q40462233 | ||
Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression | Q40583196 | ||
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points | Q40656148 | ||
Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model | Q40663418 | ||
Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector | Q40897014 | ||
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. | Q42639115 | ||
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. | Q44601270 | ||
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. | Q44825219 | ||
Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion | Q45158832 | ||
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy | Q45180665 | ||
Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model | Q45418761 | ||
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy | Q45863191 | ||
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas | Q45880512 | ||
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression | Q45881054 | ||
Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase | Q47371084 | ||
Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation | Q47752298 | ||
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis | Q49099417 | ||
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation | Q57662899 | ||
The end of the beginning: oncolytic virotherapy achieves clinical proof-of-concept | Q64378176 | ||
Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect | Q64379701 | ||
Truncated active matrix metalloproteinase-8 gene expression in HepG2 cells is active against native type I collagen | Q64380260 | ||
Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling | Q74623079 | ||
P433 | issue | 11 | |
P921 | main subject | Adenoviridae | Q193447 |
oncolytic virus | Q1560099 | ||
P304 | page(s) | 1982-1990 | |
P577 | publication date | 2007-07-24 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus | |
P478 | volume | 15 |
Q37622288 | "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment |
Q39807606 | A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses. |
Q39771175 | A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy. |
Q41846143 | A potential therapeutic strategy for malignant mesothelioma with gene medicine |
Q36951268 | Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth |
Q37857659 | Clinical development directions in oncolytic viral therapy |
Q42259034 | Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10. |
Q88692884 | Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery |
Q35585299 | Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection |
Q39194008 | Effect of increased viral replication and infectivity enhancement on radioiodide uptake and oncolytic activity of adenovirus vectors expressing the sodium iodide symporter |
Q64057182 | Experimental and computational analyses reveal that environmental restrictions shape HIV-1 spread in 3D cultures |
Q26996081 | Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy |
Q34770611 | Gene therapy progress and prospects cancer: oncolytic viruses. |
Q33895533 | Impact of tumor microenvironment on oncolytic viral therapy |
Q39003421 | Mammalian orthoreovirus T3D infects U-118 MG cell spheroids independent of junction adhesion molecule-A. |
Q64061194 | Matrix modification for enhancing the transport properties of the human cartilage endplate to improve disc nutrition |
Q37594715 | Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomography |
Q36751597 | Murine Tumor Models for Oncolytic Rhabdo-Virotherapy |
Q36058092 | Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model |
Q38673407 | Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy. |
Q26765238 | Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression |
Q38033591 | Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets |
Q38161331 | Pancreatic cancer gene therapy: from molecular targets to delivery systems |
Q47103891 | Prospects for combined use of oncolytic viruses and CAR T-cells |
Q103043779 | Regulation of circular RNAs act as ceRNA in a hypoxic pulmonary hypertension rat model |
Q37703070 | Site-specific gene therapy for cardiovascular disease. |
Q38125197 | Strategies to increase drug penetration in solid tumors |
Q64244093 | Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model |
Q38676416 | Targeting Melanoma with Cancer-Killing Viruses |
Q33613734 | Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo |
Q46448172 | The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth |
Q90080294 | The Role of MMP8 in Cancer: A Systematic Review |
Q38924554 | Therapeutic potential of oncolytic Newcastle disease virus: a critical review |
Q37209024 | Toward a stem cell gene therapy for breast cancer |
Q37311960 | Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus |
Q38128561 | Update on oncolytic viral therapy - targeting angiogenesis |